Skip to Content
Merck

Lipidomics reveals a remarkable diversity of lipids in human plasma.

Journal of lipid research (2010-07-31)
Oswald Quehenberger, Aaron M Armando, Alex H Brown, Stephen B Milne, David S Myers, Alfred H Merrill, Sibali Bandyopadhyay, Kristin N Jones, Samuel Kelly, Rebecca L Shaner, Cameron M Sullards, Elaine Wang, Robert C Murphy, Robert M Barkley, Thomas J Leiker, Christian R H Raetz, Ziqiang Guan, Gregory M Laird, David A Six, David W Russell, Jeffrey G McDonald, Shankar Subramaniam, Eoin Fahy, Edward A Dennis
ABSTRACT

The focus of the present study was to define the human plasma lipidome and to establish novel analytical methodologies to quantify the large spectrum of plasma lipids. Partial lipid analysis is now a regular part of every patient's blood test and physicians readily and regularly prescribe drugs that alter the levels of major plasma lipids such as cholesterol and triglycerides. Plasma contains many thousands of distinct lipid molecular species that fall into six main categories including fatty acyls, glycerolipids, glycerophospholipids, sphingolipids, sterols, and prenols. The physiological contributions of these diverse lipids and how their levels change in response to therapy remain largely unknown. As a first step toward answering these questions, we provide herein an in-depth lipidomics analysis of a pooled human plasma obtained from healthy individuals after overnight fasting and with a gender balance and an ethnic distribution that is representative of the US population. In total, we quantitatively assessed the levels of over 500 distinct molecular species distributed among the main lipid categories. As more information is obtained regarding the roles of individual lipids in health and disease, it seems likely that future blood tests will include an ever increasing number of these lipid molecules.

MATERIALS
Product Number
Brand
Product Description

Palmitic acid, European Pharmacopoeia (EP) Reference Standard
Supelco
Palmitic acid, certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland
Supelco
Palmitic acid, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
Myristic acid, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Palmitic acid, ≥98% palmitic acid basis (GC)
Supelco
Myristic acid, analytical standard
Sigma-Aldrich
Arachidic acid, synthetic, ≥99.0% (GC)
Supelco
γ-Linolenic acid, analytical standard
Supelco
Palmitic acid, analytical standard
Sigma-Aldrich
Coenzyme Q9, ≥96.0% (HPLC)
Supelco
Behenic acid, analytical standard
Sigma-Aldrich
Myristic acid, ≥98.0% (GC)
Sigma-Aldrich
Myristic acid, ≥95%, FCC, FG
Sigma-Aldrich
Myristic acid, natural, ≥98.5%, FG
Sigma-Aldrich
Lauric acid, natural, ≥98%, FCC, FG
Sigma-Aldrich
Lauric acid, ≥98%, FCC, FG
Sigma-Aldrich
(+)-4-Cholesten-3-one, 98%
Sigma-Aldrich
Palmitic acid, ≥98%, FCC, FG
Sigma-Aldrich
Linoleic acid, technical, 58-74% (GC)
Sigma-Aldrich
Hexacosanoic acid, technical, ≥90% (GC)
Sigma-Aldrich
Behenic acid, 99%
Sigma-Aldrich
20-Hydroxy-(5Z,8Z,11Z,14Z)-eicosatetraenoic acid, ~100 μg/mL in ethanol, ≥90% (HPLC)
Sigma-Aldrich
γ-Linolenic acid, ≥99%, liquid
Sigma-Aldrich
Linoleic acid, liquid, BioReagent, suitable for cell culture
Sigma-Aldrich
Palmitic acid, ≥99%
Sigma-Aldrich
Prostaglandin E2, γ-irradiated, powder, BioXtra, suitable for cell culture
Sigma-Aldrich
Hexacosanoic acid, ≥95% (capillary GC)
Sigma-Aldrich
Coenzyme Q10, ≥98% (HPLC)
Sigma-Aldrich
Prostaglandin E2, synthetic, powder, BioReagent, suitable for cell culture
Sigma-Aldrich
Prostaglandin E2, ≥93% (HPLC), synthetic